Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg M N Behrens

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|May 22, 2023
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individualsJoana Barros-Martins, Swantje I Hammerschmidt, Gema Morillas Ramos, et al.
Frontiers in Immunology|October 24, 2022
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsMatthias Becker, Anne Cossmann, Karsten Lürken, et al.
Frontiers in Immunology|April 1, 2022
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of ConcernIvan Odak, Christian R Schultze-Florey, Swantje I Hammerschmidt, et al.
Nature Immunology|January 18, 2006
Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunityNicholas S Wilson, Georg M N Behrens, Rachel J Lundie, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
AIDS (London, England)|October 25, 2021
The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differencesOlga Fursa, Amanda Mocroft, Jeffrey V Lazarus, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
Infectious Diseases and Therapy|September 5, 2020
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare ProfessionalsGeorg M N Behrens, Anne Cossmann, Metodi V Stankov, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|May 22, 2023
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individualsJoana Barros-Martins, Swantje I Hammerschmidt, Gema Morillas Ramos, et al.
Frontiers in Immunology|October 24, 2022
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsMatthias Becker, Anne Cossmann, Karsten Lürken, et al.
Frontiers in Immunology|April 1, 2022
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of ConcernIvan Odak, Christian R Schultze-Florey, Swantje I Hammerschmidt, et al.
Nature Immunology|January 18, 2006
Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunityNicholas S Wilson, Georg M N Behrens, Rachel J Lundie, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
AIDS (London, England)|October 25, 2021
The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differencesOlga Fursa, Amanda Mocroft, Jeffrey V Lazarus, et al.
HIV Medicine|March 26, 2022
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021Lene Ryom, Rosa De Miguel, Aoife Grace Cotter, et al.
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.
Infectious Diseases and Therapy|September 5, 2020
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare ProfessionalsGeorg M N Behrens, Anne Cossmann, Metodi V Stankov, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pageof 12